GNE-7915 [Ligand Id: 8073] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2178134
  • leucine rich repeat kinase 2/Leucine-rich repeat serine/threonine-protein kinase 2 in Human [ChEMBL: CHEMBL1075104] [GtoPdb: 2059] [UniProtKB: Q5S007]
There should be some charts here, you may need to enable JavaScript!
  • TTK protein kinase in Human [GtoPdb: 2264] [UniProtKB: P33981]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
leucine rich repeat kinase 2/Leucine-rich repeat serine/threonine-protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075104] [GtoPdb: 2059] [UniProtKB: Q5S007]
ChEMBL LabChip Assay: This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In a polypropylene plate, LRRK2, fluorescently-labeled peptide substrate, ATP and test compound were incubated together. Using a LabChip 3000 (Caliper Life Sciences), after the reaction the substrate was separated by capillary electrophoresis into two populations: phosphorylated and unphosphorylated. The relative amounts of each were quantitated by fluorescence intensity. B 8.7 pKi 2 nM Ki US-8802674-B2. Aminopyrimidine derivatives as LRRK2 modulators (2014)
GtoPdb - - 9 pKi 1 nM Ki J Med Chem (2014) 57: 921-36 [PMID:24354345]
ChEMBL Inhibition of LRRK2 using FAM-LRRKtide as substrate after 120 mins by microfluidic capillary electrophoresis assay B 9 pKi 1 nM Ki J Med Chem (2012) 55: 9416-9433 [PMID:22985112]
ChEMBL Inhibition of LRRK2 G2019S mutant (unknown origin) B 9 pKi 1 nM Ki J Med Chem (2020) 63: 11330-11361 [PMID:32352776]
ChEMBL Inhibition of recombinant human wild type GST-tagged LRRK2 (970 to 2527 residues) preincubated for 30 mins followed by fluorescein-LRRKtide substrate addition after 2 hrs by TR-FRET assay B 7.01 pIC50 97 nM IC50 Bioorg Med Chem Lett (2017) 27: 4500-4505 [PMID:28802631]
ChEMBL Inhibition of recombinant human LRRK2 (970 to 2527 residues) G2019S mutant expressed in baculovirus preincubated for 30 mins followed by fluorescein-LRRKtide substrate addition after 2 hrs by TR-FRET assay B 7.34 pIC50 46 nM IC50 Bioorg Med Chem Lett (2017) 27: 4500-4505 [PMID:28802631]
ChEMBL Inhibition of autophosphorylation of LRRK2 in human HEK293 cells B 8.05 pIC50 9 nM IC50 J Med Chem (2012) 55: 9416-9433 [PMID:22985112]
GtoPdb Inhibition of autophosphorylation in a cellular assay. - 8.05 pIC50 9 nM IC50 J Med Chem (2014) 57: 921-36 [PMID:24354345]
TTK protein kinase in Human [GtoPdb: 2264] [UniProtKB: P33981]
GtoPdb - - 7.28 pKi 53 nM Ki J Med Chem (2014) 57: 921-36 [PMID:24354345]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]